Implantica AG
STO: IMP-A-SDB.ST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Stockholm Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Peter Forsell
- Employees
- 50
- Headquarters
- Vaduz, Liechtenstein
- IPO year
- 2020
- Market cap
- SEK 2.6B
- Website
- https://www.implantica.com
Loading IMP-A-SDB…
Loading profile data…Frequently asked questions about IMP-A-SDB
What does Implantica AG (IMP-A-SDB.ST) do?
Implantica AG, a medtech company, researches, develops, and sells medical implants for unmet medical needs in Switzerland. Its lead product candidate is RefluxStop, a passive CE-marked implant for prevention of gastroesophageal reflux disease. The company also develops e-InVivo, a sensor implant to monitor a multitude of health parameters and pr...
Where does IMP-A-SDB.ST trade?
Implantica AG (IMP-A-SDB.ST) trades on the Stockholm Stock Exchange.
What sector is IMP-A-SDB.ST in?
Implantica AG (IMP-A-SDB.ST) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Implantica AG?
Peter Forsell is the chief executive officer of Implantica AG (IMP-A-SDB.ST).
Where is Implantica AG headquartered?
Implantica AG is headquartered in Liechtenstein.
Does IMP-A-SDB.ST pay a dividend?
Implantica AG (IMP-A-SDB.ST) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did IMP-A-SDB.ST go public?
Implantica AG (IMP-A-SDB.ST) completed its initial public offering in 2020.